Overwatch Research raised $3.5M in a round led by Frontline Ventures.

Overwatch Research, a Belfast, UK-based software devleoper of a tracking tool for healthcare, announced that it raised $3.5 million.

The money was raised from investors led by Frontline Ventures, and joined by SV Angel, Techstart Ventures, and angels Michael Polansky (CEO of The Parker Group and Co-founder of Parker Institute for Cancer Immunology), Zach Weinberg, the Co-founder of Flatiron Health (a major manager of real-world oncology data acquired by Roche in 2018), and Robert Fenton, CEO of Qualio (cloud-based data management system for life sciences companies).

Overwatch Research, founded in 2017 by CEO Chris Armstrong, provides an all-in-one experimental tracking software for Vivo research, helping solve the reproducibility crisis and focusing on the 3Rs.

The company previously raised $800k in a preseed round.